Recombinant Deoxyribonucleoside Kinase from Drosophila Melanogaster Can Improve Gemcitabine Based Combined Gene Chemotherapy for Targeting Cancer Cells. Biomol Biomed 2019, 19 (4), 342-349. https://doi.org/10.17305/bjbms.2019.4136.